Assembly Biosciences Stock Forecast
Green day on Friday for Assembly Biosciences stock after gaining 0.82%
(Updated on May 26, 2023)
The Assembly Biosciences stock price gained 0.82% on the last trading day (Friday, 26th May 2023), rising from $0.97 to $0.98. During the last trading day the stock fluctuated 4.17% from a day low at $0.96 to a day high of $1.00. The price has fallen in 6 of the last 10 days and is down by -6.67% for this period. Volume fell on the last day by -109 thousand shares and in total, 71 thousand shares were bought and sold for approximately $69.19 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.99 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -24.15% during the next 3 months and, with a 90% probability hold a price between $0.456 and $0.748 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
ASMB Signals & Forecast
There are few to no technical positive signals at the moment. The Assembly Biosciences stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.03 and $1.01. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 17, 2023, and so far it has fallen -13.27%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Assembly Biosciences stock
Assembly Biosciences finds support from accumulated volume at $0.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 4.17%. For the last week the stock has had daily average volatility of 7.31%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ASMB) For The Upcoming Trading Day Of Tuesday 30th
For the upcoming trading day on Tuesday, 30th we expect Assembly Biosciences to open at $0.98, and during the day (based on 14 day Average True Range), to move between $0.91 and $1.05, which gives a possible trading interval of +/-$0.0724 (+/-7.39%) up or down from last closing price. If Assembly Biosciences takes out the full calculated possible swing range there will be an estimated 14.78% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.98 (0.46%) than the support at $0.95 (3.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Assembly Biosciences stock A Buy?
Assembly Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -4.631 Open Broker Account
Sell Candidate UnchangedPredicted Opening Price for Assembly Biosciences of Tuesday, May 30, 2023
The predicted opening price is based on yesterday's movements between high, low, and closing price.
| Fair opening price May 30, 2023 | Current price |
|---|---|
| $0.98 | $0.98 (Undervalued) |
Remember To Visit Our YouTube Channel
Trading levels for ASMB
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.02 | 4.08 % | |
| R2 | 1.00 | 2.52 % | ||
| R1 | 1.00 | 1.56 % | ||
| Current price: | 0.98 | |||
| Support | S1 | 0.96 | -1.56 % | |
| S2 | 0.96 | -2.52 % | ||
| S3 | 0.94 | -4.08 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.09 | 11.22 % | |
| R2 | 1.07 | 9.18 % | ||
| R1 | 0.98 | 0.459 % | ||
| Current price | 0.98 | |||
| Support | S1 | 0.95 | -3.06% | |
| S2 | 0.92 | -6.12% | ||
| S3 | 0.80 | -18.37% |
FAQ
Click here for our free guide on how to buy Assembly Biosciences Stock.
About Assembly Biosciences
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
